5-y survival of lung cancer

• ~70–90% for stage I,
• 50–60% stage II,
• 15–35% stage III,
• 0–10% stage IV (J Thorac Oncol 2016;11:39);
• survival improving with newer therapies (NEJM 2020;383:640).

REF:

The Effect of Advances in Lung-Cancer Treatment on Population Mortality